Minister of Foreign Affairs Nikos Dendias to meet with Kosovar Minister of Foreign Affairs, Donika Gërvalla – Schwarz (Athens, 20.01.2022)

Minister of Foreign Affairs, Nikos Dendias, will meet in Athens tomorrow, Thursday, January 20, 2022, with Kosovar Minister of Foreign Affairs, Donika Gërvalla – Schwarz.

Expanded talks will be followed by joint statements to the press scheduled to be made at approximately 13:30.

Foreign Minister Gërvalla-Schwarz’s visit to Athens follows Minister of Foreign Affairs Nikos Dendias’ visit to Pristina last June.

The talks are expected to focus on Athens-Pristina co-operation in the fields of economy, trade and culture, as well as on regional issues, including the European perspective of the Western Balkans and the Belgrade-Pristina dialogue.

Kate Onyejekwe, experte en santé publique, dirigera le bureau de Washington de JSI

WASHINGTON, 19 janvier 2022 /PRNewswire/ — John Snow, Inc. (JSI), est fier d’annoncer que Kate Onyejekwe a été nommée au poste de directrice du bureau de la Division internationale à Washington, DC.

Kate Onyejekwe

Mme Onyejekwe  assurera la direction et la supervision de la programmation du portefeuille de 75 projets dans 40 pays, de sept centres de compétences techniques et des équipes de services aux entreprises du bureau de Washington, DC.

« Ma passion a toujours été de servir les gens et les collectivités partout dans le monde pour créer des systèmes de santé solides, renforcer la résilience et faciliter des services de santé équitables pour tous. Ce rôle offre une plate-forme encore plus grande à la Division internationale et à JSI dans son ensemble pour continuer à façonner et à faire progresser le programme mondial de santé publique », a déclaré Mme Onyejekwe.

Plus récemment, Mme Onyejekwe était directrice adjointe du programme MOMENTUM Integrated Health Resilience, où elle supervisait le personnel mondial et les partenariats régionaux et nationaux pour atteindre les objectifs de programmation au niveau national.

Mme Onyejekwe possède plus de 25 ans d’expérience technique et en gestion de programmes dans les domaines de la planification familiale et de la santé génésique, de la santé maternelle et infantile, de l’immunisation, des programmes relatifs au VIH, au genre et à la jeunesse, de la santé communautaire, du renforcement des capacités, de la gestion pharmaceutique et de la gestion financière et opérationnelle dans des contextes multiculturels. Son travail dans plus de 14 pays souligne son engagement à innover et à galvaniser les nations, les communautés, les familles et les individus afin qu’ils perfectionnent leurs compétences et créent des solutions durables à leurs problèmes de santé et de développement prioritaires, en particulier pendant l’ère de la COVID-19.

John Snow, Inc. , et le JSI Research & Training Institute sont des organismes de consultation en gestion de la santé publique et de recherche voués à l’amélioration de la santé des personnes et des communautés partout dans le monde. Nous travaillons en partenariat avec des organismes communautaires, le secteur privé et des agences gouvernementales afin de renforcer leur capacité de rationaliser les services, de former leur personnel, de recueillir et d’utiliser des données, de promouvoir des comportements sains, et consolider les chaînes d’approvisionnement afin de fournir de meilleurs services de santé à tous.

Contact :
Pamela Bond, Conseillère principale en communication
pamela_bond@JSI.com

John Snow, Inc. Logo

Photo – https://mma.prnewswire.com/media/1729021/Kate_Onyejekwe.jpg

Logo – https://mma.prnewswire.com/media/400895/JSI_Logo.jpg

 

Public Health Expert Kate Onyejekwe to Lead JSI’s Washington Office

WASHINGTON, Jan. 19, 2022 /PRNewswire/ — John Snow, Inc. (JSI), is proud to announce that Kate Onyejekwe has been appointed to the position of International Division Washington, DC, office director.

Kate Onyejekwe

Onyejekwe will provide leadership and programmatic oversight to the Washington, DC-based portfolio of 75 projects in 40 countries, seven technical core competency centers, and the office’s corporate services teams.

“My passion has always been to serve people and communities around the world to engender strong health systems, build resilience, and facilitate equitable health services for all. This role provides an even greater platform for the International Division, and JSI as a whole, to continue to shape and advance the global public health agenda,” said Onyejekwe.

Most recently, Onyejekwe was deputy director of the MOMENTUM Integrated Health Resilience program, where she oversaw global staff and regional and country-level partnerships to achieve country-level programming goals.

John Snow, Inc. Logo Onyejekwe has more than 25 years of technical and program management experience in family planning and reproductive health; maternal and child health; immunization; HIV gender and youth programming; community health; capacity building; pharmaceutical  management; and  financial and operational management in multicultural settings. Her work in more than 14 countries underpins her commitment to innovate with and galvanize nations, communities, families, and individuals to advance their skills and create lasting solutions to their priority health and development challenges, especially during the COVID-19 era.

John Snow, Inc, and the nonprofit JSI Research & Training Institute are public health management consulting and research organizations dedicated to improving the health of individuals and communities throughout the world. We partner with community-based organizations, the private sector, and government agencies to strengthen their capacity to streamline services, develop their workforce, collect and use data, promote healthy behaviors, and strengthen supply chains in an effort to deliver better health services to all.

Contact:
Pamela Bond, Senior Communications Advisor
pamela_bond@JSI.com

Seegene to Launch New COVID-19 PCR Test with a Reduced Turnaround Time Optimized for Mass Testing

Scheduled to launch in late January, Seegene’s new COVID-19 test supports swift, large-scale lab testing with the same degree of accuracy as the conventional PCR test

SEOUL, South Korea, Jan. 19, 2022 /PRNewswire/ — Seegene Inc. (KQ 096530), South Korea’s leading molecular diagnostics company, announced today the upcoming launch of the Allplex™ SARS-CoV-2 Fast PCR Assay, which can deliver PCR results in just 60 minutes. The company says that this assay is expected to reduce the total turnaround time to a third and expand testing capacity up to 3 times for hospitals and laboratories without additional instruments or compromise on accuracy.

Reduction of the turnaround time was attributable to two primary reasons: 1) the application of a novel enzyme developed by Seegene, which reduces PCR process time to half. 2) Seegene’s innovative extraction-free method, which can let Allplex™ SARS-CoV-2 Fast PCR Assay be available without the extraction of the sample preparation in PCR-based tests. This drastically reduces the total turnaround time for each result. As such, the new assay lessens the amount of hands-on processing time required, allowing facilities to triple their testing capacity in the same hour.

Logo

“This assay will be the optimized choice for laboratories and hospitals where they conduct large-scale testing as it helps them immediately expand the testing capacity with lessening the burden of healthcare workers,” said Ho Yi, Chief Sales and Marketing Officer of Seegene. “For the time being, we plan to target large-scale testing markets in more than 60 countries all across the globe. The next step in our journey is to develop a new gold-standard molecular diagnostic assay that fully matches the speed of antigen tests with the same degree of accuracy as PCR test”

The Allplex™ SARS-CoV-2 Fast PCR Assay targets three COVID-19 genes––E, RdRP, and N–– to reliably detect COVID-19 regardless of the variants. According to clinical research conducted by 17 laboratories in seven countries, this assay showed the same or better accuracy for the COVID-19 detection as other diagnostic tests available in the market.

Visit www.seegene.com for more information.

About Seegene, Inc.

Seegene, Inc. was founded in Seoul, South Korea in 2000 and has subsidiaries in the U.S.A., Canada, Germany, Italy, Mexico, Brazil, Colombia, and the Middle East. Seegene, Inc. is an in-vitro diagnostics (IVD) company that has been turning innovative technologies into products through its pioneering R&D activities. Seegene owns its original patent technology including DPO™ (Dual Priming Oligonucleotide) for multiple target amplification; TOCE™ for multiple target detection in a single channel; MuDT™, the world’s first real-time PCR technology that provides individual Ct values for multiple targets in a single channel for quantitative assays.; and mTOCE™ multiplex mutation detection technology. With these cutting-edge molecular diagnostic (MDx) technologies applied to diagnostic kits and other tools, Seegene has enhanced the sensitivity, specificity, and disease-coverage per a test of PCR (polymerase chain reaction) to unprecedented levels by providing accurate high-multiplex PCR products that target and detect genes of multiple pathogens simultaneously per each fluorescence channel. This feature dramatically saves testing time and cost. Seegene continues to set new standards in MDx through cutting-edge innovations.

Photo – https://mma.prnewswire.com/media/1728443/N.jpg

Logo – https://mma.prnewswire.com/media/1357790/Seegene_logo_Logo.jpg

Investigating a Massacre, Iraq Should Address Root Causes

On December 31, Iraqi security forces killed 20 people from a single family in a raid on a home in Jableh district in Babil governorate, south of Baghdad. Security forces carried out the raid after reportedly receiving false information about a suspect purportedly living there. While the Iraqi government swiftly opened an investigation, the authorities should examine how security forces often appear to rely on unsubstantiated, questionable, and/or false information to target suspects, especially alleged ISIS members.
On January 3, the Iraqi judiciary charged 13 people – including 9 state security personnel for their involvement in the Jableh operation and killings. Iraq’s High Judicial Council said in a statement that a relative of one of the victims provided “false information as a result of family disputes.” Prime Minister Mustafa al-Kadhimi also subsequently dismissed senior officers in Babil, including the police chief in Babil governorate and intelligence chiefs in Jableh and Babil, and formed a committee of senior security officials to investigate the massacre.
The Iraqi government’s quick and high-profile actions are a positive response to these killings. But the authorities have previously formed committees to investigate human rights violations while failing to publicly disclose any findings. There has been little transparency on any measures to sanction those responsible, nor have there been any structural changes to address the root causes of these abuses. The committee should directly address how unsubstantiated information is often used to justify targeting and arresting suspects.
Human Rights Watch has long documented the misuse and abuse of Iraq’s anti-terrorism laws and policies. Iraqi authorities, for instance, continue to rely on unverified information provided to them by secret informants about former ISIS members and sympathizers. Media and Human Rights Watch reporting has shown that some residents and families have exploited security forces’ reliance on often unsubstantiated accusations from informants to settle personal and family disputes.
Reports indicate that in this case, the informant who provided the false information was a police officer himself, raising still more concern about the perversion of anti-terrorism laws and policies among those tasked with enforcing them.
The Jableh massacre is a tragedy. It will be even more devastating if the authorities who claim they intend to prevent another like it fail to address the structural issues that helped facilitate these killings.

Source: Human Rights Watch